Tenderwize
Wróć do wyszukiwania

Supply of Medicinal Products

GCS UniHA·LYON, France·EUR 834.6M·Deadline Nov 24, 2031 · 1919 days left·Restricted·Supplies·DPS
Zarejestruj się, aby zapisaćOpen documents
High value
Oryginalny tytuł ogłoszenia

France – Pharmaceutical products – UniHA_Fourniture de médicaments

80/100

Ocena szansy

PromisingMedium complexity
SuppliesDPSOpen
Skąd ta ocena?

Szansa

80 / 100

Złożoność

60 / 100

Czynniki ryzyka

EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...

Award criteria and detailed selection requirements are not provided in the notice.

Restricted procedure — pre-qualification required

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • EUR 834.6M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 120 MONTH
  • Supply of medicinal products from identified therapeutic areas (annex 1 of the CCTP).
  • Supply of equivalent medical devices meeting same technical requirements.
Pokaż pełne podsumowanie

This is a corrigendum of a Dynamic Purchasing System (SAD) for the supply of pharmaceutical products to member establishments of UniHA in France. The DPS covers various therapeutic areas and lasts 120 months. The estimated total value is €834,612,170. The procedure is restricted, and applications can be submitted until 24 November 2031. Note: There is an inconsistency regarding EU funding (structured data says EU-funded, XML notice says no EU funds).

Ryzyka

EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...

Award criteria and detailed selection requirements are not provided in the notice.

Restricted procedure — pre-qualification required

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Admission to the Dynamic Purchasing System (SAD) is required.
  • Selection based on economic, financial, and professional capacity as per article 7.2 of the RC.
  • Candidates may be asked to update their application during the DPS validity.

Kryteria udzielenia

Lot 1

Not specified in provided data; award criteria will be defined in each specific contract under the DPS.

Zamawiający

Lokalizacja

LYON, FRA

Profil zamawiającego

Otwórz profil

Identyfikator

130 002 223 00043

Działalność

Health

Części (1)

LOT-0001

Supply of Medicinal Products

Supply of medicinal products from identified therapeutic areas (annex 1) and equivalent medical devices to UniHA member establishments.

SuppliesDPSEU fundedElectronic submissionSME suitable

EUR 834.6M

Szacowana wartość

Lokalizacja

Lieu principal d'exécution : Le territoire national. Le lieu d'exécution sera précisé dans les marchés spécifiques, France

Czas trwania

120 MONTH

Kategoria

Pharmaceutical products

Kryteria udzielenia

Not specified in provided data; award criteria will be defined in each specific contract under the DPS.

Termin

Deadline Nov 24, 2031

Szczegóły zamówienia

Data publikacji
13 Apr 2026
Języki
French

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
252871-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3